Melahat Coban1, Ayca Inci2. 1. Division of Nephrology, Antalya Training and Research Hospital, Antalya, Turkey. 2. Division of Nephrology, Antalya Training and Research Hospital, Antalya, Turkey. aycainci2004@hotmail.com.
Abstract
PURPOSE: Autosomal dominant polycystic kidney disease (ADPKD) is a common congenital chronic kidney disease (CKD). We report here the relationship of serum angiopoietin-1 (Ang-1), Ang-2, and vascular endothelial growth factor (VEGF) with total kidney volume (TKV), total cyst volume (TCV), and renal failure in adult ADPKD patients at various stages of CKD. METHODS: This cross-sectional study was conducted with 50 patients diagnosed with ADPKD and a control group of 45 age-matched healthy volunteers. In patient group, TKV and TCV were determined with upper abdominal magnetic resonance imaging, whereas in controls, TKV was determined with ultrasonography according to ellipsoid formula. Renal function was assessed with serum creatinine, estimated glomerular filtration rate (eGFR), and spot urinary protein/creatinine ratio (UPCR). Ang-1, Ang-2, and VEGF were measured using enzyme-linked immunosorbent assay. RESULTS: Patients with ADPKD had significantly higher TKV (p < 0.001) and UPCR (p < 0.001), and lower eGFR (p ≤ 0.001) compared to the controls. Log10Ang-2 was found to be higher in ADPKD patients at all CKD stages. Multiple linear regression analysis showed that there was no association between log10Ang-1, log10Ang-2, or log10VEGF and creatinine, eGFR, UPCR, log10TKV (p > 0.05). CONCLUSION: There was no association of serum angiogenic growth factors with TKV or renal failure in ADPKD patients. Increased serum Ang-2 observed in stages 1-2 CKD suggests that angiogenesis plays a role in the progression of early stage ADPKD, but not at later stages of the disease. This may be explained by possible cessation of angiogenesis in advanced stages of CKD due to the increased number of sclerotic glomeruli.
PURPOSE:Autosomal dominant polycystic kidney disease (ADPKD) is a common congenital chronic kidney disease (CKD). We report here the relationship of serum angiopoietin-1 (Ang-1), Ang-2, and vascular endothelial growth factor (VEGF) with total kidney volume (TKV), total cyst volume (TCV), and renal failure in adult ADPKDpatients at various stages of CKD. METHODS: This cross-sectional study was conducted with 50 patients diagnosed with ADPKD and a control group of 45 age-matched healthy volunteers. In patient group, TKV and TCV were determined with upper abdominal magnetic resonance imaging, whereas in controls, TKV was determined with ultrasonography according to ellipsoid formula. Renal function was assessed with serum creatinine, estimated glomerular filtration rate (eGFR), and spot urinary protein/creatinine ratio (UPCR). Ang-1, Ang-2, and VEGF were measured using enzyme-linked immunosorbent assay. RESULTS:Patients with ADPKD had significantly higher TKV (p < 0.001) and UPCR (p < 0.001), and lower eGFR (p ≤ 0.001) compared to the controls. Log10Ang-2 was found to be higher in ADPKDpatients at all CKD stages. Multiple linear regression analysis showed that there was no association between log10Ang-1, log10Ang-2, or log10VEGF and creatinine, eGFR, UPCR, log10TKV (p > 0.05). CONCLUSION: There was no association of serum angiogenic growth factors with TKV or renal failure in ADPKDpatients. Increased serum Ang-2 observed in stages 1-2 CKD suggests that angiogenesis plays a role in the progression of early stage ADPKD, but not at later stages of the disease. This may be explained by possible cessation of angiogenesis in advanced stages of CKD due to the increased number of sclerotic glomeruli.
Authors: Shagun Raina; Michael Honer; Stefanie D Krämer; Yang Liu; Xueqi Wang; Stephan Segerer; Rudolf P Wüthrich; Andreas L Serra Journal: Am J Physiol Renal Physiol Date: 2011-06-15
Authors: Sascha David; Philipp Kümpers; Alexander Lukasz; Danilo Fliser; Jens Martens-Lobenhoffer; Stefanie M Bode-Böger; Volker Kliem; Hermann Haller; Jan T Kielstein Journal: Nephrol Dial Transplant Date: 2010-02-22 Impact factor: 5.992
Authors: Berenice Y Reed; Amirali Masoumi; Elwaleed Elhassan; Kim McFann; Melissa A Cadnapaphornchai; David M Maahs; Janet K Snell-Bergeon; Robert W Schrier Journal: Kidney Int Date: 2010-09-29 Impact factor: 10.612
Authors: T Ostendorf; U Kunter; F Eitner; A Loos; H Regele; D Kerjaschki; D D Henninger; N Janjic; J Floege Journal: J Clin Invest Date: 1999-10 Impact factor: 14.808
Authors: Claudia R Amura; Kelley S Brodsky; Rachel Groff; Vincent H Gattone; Norbert F Voelkel; R Brian Doctor Journal: Am J Physiol Cell Physiol Date: 2007-05-02 Impact factor: 4.249
Authors: Matthew T Nichols; Elsa Gidey; Tom Matzakos; Rolf Dahl; Greg Stiegmann; Raj J Shah; Jared J Grantham; J Gregory Fitz; R Brian Doctor Journal: Hepatology Date: 2004-10 Impact factor: 17.425
Authors: Kristal O'Brien; Sayanthooran Saravanabavan; Jennifer Q J Zhang; Annette T Y Wong; Alexandra Munt; Jane S Burgess; Gopala K Rangan Journal: Int J Nephrol Renovasc Dis Date: 2020-04-01